FOXO and FOXM1 in Cancer: The FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy

Wilson, Miranda S. C.; Brosens, Jan J.; Schwenen, Helma D. C.; Lam, Eric W.-F.
August 2011
Current Drug Targets;Aug2011, Vol. 12 Issue 9, p1256
Academic Journal
No abstract available.


Related Articles

  • Loss of Foxm1 Results in Reduced Somatotrope Cell Number during Mouse Embryogenesis. Calderon, Michael J.; Ploegman, Adam G.; Bailey, Brock; Jung, Deborah O.; Navratil, Amy M.; Ellsworth, Buffy S. // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    FOXM1, a member of the forkhead box transcription factor family, plays a key role in cell cycling progression by regulating the expression of critical G1/S and G2/M phase transition genes. In vivo studies reveal that Foxm1 null mice have a 91% lethality rate at e18.5 due to significant...

  • Deciphering the Role of Forkhead Transcription Factors in Cancer Therapy. Jer-Yen Yang; Mien-Chie Hung // Current Drug Targets;Aug2011, Vol. 12 Issue 9, p1284 

    No abstract available.

  • The yin and yang of E2F-1: balancing life and death. La Thangue, Nicholas B. // Nature Cell Biology;Jul2003, Vol. 5 Issue 7, p587 

    E2F transcription factors coordinate the timely expression of genes during early cell-cycle progression. In addition, the E2F-1 subunit can induce apoptosis in response to DNA damage. New results reveal an unexpected function for E2F-1 in suppressing apoptosis, which may be important in...

  • Stress-specific response of the p53-Mdm2 feedback loop. Hunziker, Alexander; Jensen, Mogens H.; Krishna, Sandeep // BMC Systems Biology;2010, Vol. 4, p94 

    Background: The p53 signalling pathway has hundreds of inputs and outputs. It can trigger cellular senescence, cell-cycle arrest and apoptosis in response to diverse stress conditions, including DNA damage, hypoxia and nutrient deprivation. Signals from all these inputs are channeled through a...

  • FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial. Ladoire, S.; Mignot, G.; Dalban, C.; Chevriaux, A.; Arnould, L.; Rébé, C.; Apetoh, L.; Boidot, R.; Penault-Llorca, F.; Fumoleau, P.; Roché, H.; Spielmann, M.; Levy, C.; Lortholary, A.; Eichler, F.; Mesleard, C.; Bonnetain, F.; Ghiringhelli, F. // Annals of Oncology;Oct2012, Vol. 23 Issue 10, p2552 

    Background Predictive markers of response to chemotherapy are lacking in breast cancer patients. Forkhead Box Protein 3 (FOXP3) is an anti-oncogene whose absence in cancer cells could confer resistance to DNA damaging agent. So we made the hypothesis that FOXP3 expression predicts the response...

  • Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases. Horimoto, Y; Arakawa, A; Harada-Shoji, N; Sonoue, H; Yoshida, Y; Himuro, T; Igari, F; Tokuda, E; Mamat, O; Tanabe, M; Hino, O; Saito, M // British Journal of Cancer;1/20/2015, Vol. 112 Issue 2, p345 

    Background:FOXA1 expression is a good prognostic marker for endocrine therapy in hormone-positive breast cancer. We retrospectively examined breast cancer patients with luminal human epidermal growth factor receptor 2 (HER2)-negative tumours, as defined by immunohistochemistry, who received...

  • Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells. Bhat, Uppoor G.; Halasi, Marianna; Gartel, Andrei L. // PLoS ONE;2009, Vol. 4 Issue 5, p1 

    Forkhead box M1 (FoxM1) oncogenic transcription factor represents an attractive therapeutic target in the fight against cancer, because it is overexpressed in a majority of human tumors. Recently, using a cell-based assay system we identified thiazole antibiotic Siomycin A as an inhibitor of...

  • Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1. Qin, Yan; Li, Longhai; Wang, Fang; Zhou, Xinyi; Liu, Yankui; Qi, Xiaowei; Yin, Yuan // Cellular Physiology & Biochemistry (Karger AG);Aug2018, Vol. 48 Issue 4, p1628 

    Background/Aims: Aberrant expression of microRNAs (miRNAs) is found to be responsible for tumorigenesis, cancer development and chemoresistance. Although oxaliplatin is an effective chemotherapeutic drug for treatment of colorectal cancer (CRC), CRC cells can develop some mechanisms...

  • Splice Variants of the Forkhead Box Protein AFX Exhibit Dominant Negative Activity and Inhibit AFXα-Mediated Tumor Cell Apoptosis. Eun Jig Lee; Jeong Mo Kim; Mi Kyung Lee; Jameson, J. Larry // PLoS ONE;2008, Vol. 3 Issue 7, p1 

    Background: Loss-of-function in the apoptosis-inducing genes is known to facilitate tumorigenesis. AFX (FOXO4), a member of forkhead transcription factors functions as a tumor suppressor and has 2 isoforms, AFXα (505 a.a.) and AFXζ (450 a.a.). In human cancer cells, we identified an...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics